The Traditional Chinese Medicine Market To Witness An Escalating CAGR Of 5.1%

Posted by Ashish on April 21st, 2021

Traditional Chinese medicine is one of the oldest systems of health and wellness that has been used in China for thousands of years. Other medicines mainly focus on treating a disease. But traditional Chinese medicines aim to increase immune power and look at the entire well-being. The most common type of traditional Chinese medicines includes herbal products, acupuncture, and Tai Chi, among others.

According to a latest report published by PMR, the global traditional Chinese medicine market is expected to witness a CAGR of more than 5% over the forecast period (2020–2030).

Strategizing The Moves For The Next Decade? See Through Sample Of Traditional Chinese Medicine Market Report! https://www.persistencemarketresearch.co/samples/16219

Companies covered in Traditional Chinese Medicine Market Report

• Tongrentang
• Zhongxin Pharmaceuticals
• Tianjin Tasly Group
• Yuannan Baiyao
• Solstice Medicine Company, Inc.
• Shanghai Sundise Traditional Chinese Medicine Co., Ltd
• China Chinese Medicine Holding Co., Ltd.
• Hunan goldliloo pharmaceutical Co., Ltd
• Wanbang Pharma Group Corp.
• Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.
• Pfizer Inc.
• Eli Lilly and Company
• Novartis AG
• GlaxoSmithKline PLC
• Mallinckrodt Pharmaceuticals
• Hisamitsu Pharmaceutical Co., Inc.